Skip to content
value.today

Carolina Molecular Inc.

Total raised
$1 M
1 round on record
Latest round
$1 M
Sep 2025
First round on record
Sep 2025
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Carolina Molecular Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2025$1 MNo. 1Under $2 million

Carolina Molecular Inc.: Raise no. 1, Sep 2025

Investors in this round

8 investors had bought by the notice of Nov 13, 2025: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $2 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Trent Carrier · Executive Officer, Director
  • John Corliss · Director
  • Max Weis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for working capital, which may include normal compensation to executive officers.”

Signed by Trent Carrier, President. Newest notice filed Nov 13, 2025. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Carolina Molecular Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2025).

    SEC Form D · Nov 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Nov 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Carolina Molecular Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Carolina Molecular Inc.
NameRoleNamed in
Trent CarrierExecutive officerNov 2025
John CorlissDirectorNov 2025
Max WeisDirectorNov 2025
Trent CarrierDirectorNov 2025